Cargando...
Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction
The objective of this study is to explore whether procalcitonin (PCT) can serve as an early biomarker of malignant cerebral edema in patients with massive cerebral infarction (MCI). Ninety-three patients with acute MCI were divided into death or survival groups based on whether they died or survived...
Guardado en:
| Publicado en: | Sci Rep |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5772664/ https://ncbi.nlm.nih.gov/pubmed/29343753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-19267-4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|